CTOs on the Move

SurgiMa

www.surgima.com

 
SurgiMa is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.surgima.com
  • 809 San Antonio Rd Ste 1
    Palo Alto, CA USA 94303
  • Phone: 650.494.0210

Executives

Name Title Contact Details

Similar Companies

Progressive Medical International

Progressive Medical International is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Charm Health

Charm Health is a Bardon Qld, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Instrumentation Laboratory

Instrumentation Laboratory is a Lexington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Inergetics

Inergetics is a leading developer of advanced proprietary nutritional products that improve overall health, physical recovery, athletic performance and quality of life for patients and consumers. Whether it`s maintaining a healthy diet, gaining strength, increasing energy, or helping to maintain your activity level at an advanced age, Inergetics offers a line of nutritional supplement that fits your lifestyle, and which you can consistently rely on.

iCAD

With iCAD`s technology, cancer has finally met its match. As a global medical technology leader providing innovative cancer detection and therapy solutions, our technologies empower clinicians worldwide with an arsenal of tools to detect cancer and stop it in its tracks – streamlining workflow, improving accuracy, and personalizing results like never before. The ProFound AI Breast Health Suite is the first, best, and only complete, triple-threat solution that combines cancer detection, density assessment, and risk evaluation – all designed to accelerate discovery and improve outcomes. Our leading-edge cancer detection solution, ProFound AI®, is clinically proven to find cancers earlier and with greater accuracy, while slashing reading time for radiologists by more than half. PowerLook® Density Assessment simplifies and standardizes breast density reporting and stratification, offering consistent, accurate and reliable breast density categorization. And the latest addition to our Breast AI Suite, ProFound AI® Risk, is the world`s first clinical decision support tool that provides an accurate short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram. Our Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is transforming the cancer treatment experience by empowering physicians to precisely and effectively target tumors anywhere in the body, anywhere in the world. Using the world`s smallest X-ray source, clinicians can precisely destroy disease while preserving healthy tissue, leaving cancer nowhere to hide.